about the author

ENDPOINTS

editor@endpointsnews.com

author articles

Sofinno­va Telethon Fund backs Nal­dini's gene ther­a­py biotech; ORIC prices $75M IPO

6 years ago
News Briefing

Covid-19 roundup: HHS of­fi­cial Giroir takes on role of test­ing czar — cue new con­tro­ver­sy; Wuhan lab ve­he­ment­ly ...

6 years ago
Coronavirus

Dorothee Kern’s path from bas­ket­ball star to founder of bil­lion-dol­lar biotech(s?); Five Prime Ther­a­peu­tics hands ...

6 years ago
Peer Review

Gala­pa­gos finds Pol­ish part­ner for in­flam­ma­tion drugs; Zai Lab's Ze­ju­la app gets speedy re­view in Chi­na

6 years ago
News Briefing

Mer­ck launch­es the lat­est Her­ceptin knock­off; Har­vard spin­out grabs a $5M seed round

6 years ago
News Briefing

Al­ny­lam's new pipeline star gets on FDA fast track; ARCH-backed biotech nabs or­phan drug sta­tus

6 years ago
News Briefing

Pfiz­er nabs col­orec­tal can­cer OK for Braftovi; Bris­tol My­ers, Pfiz­er pull out of re­gion­al deal with Por­to­la

6 years ago
News Briefing

Fred­er­ic Pla en­list­ed as COO at the Park­er In­sti­tute; For­mer Alk­er­mes ex­ec named CMO at Seres Ther­a­peu­tics

6 years ago
Peer Review

Covid-19 roundup: Pfiz­er hus­tling up mil­lions of dos­es of vac­cine — de­tails $748M BioN­Tech deal; CDC tweaks stance ...

6 years ago
Coronavirus

Covid-19 roundup: EU‘s top sci­en­tist re­signs in re­buke to agency’s Covid re­sponse; J&J posts neg­a­tive da­ta for ...

6 years ago
Coronavirus

Well­come looks for back­ers of an $8B-plus Covid-19 fund; ReNeu­ron signs on an­oth­er phar­ma part­ner

6 years ago
News Briefing

Covid-19 roundup: Ex-FDA com­mish Got­tlieb joins Re­pub­li­can gov­er­nor's coro­n­avirus team; Phar­ma ap­proval rat­ings ...

6 years ago
Coronavirus

The 20 un­der 40: In­side the next gen­er­a­tion of bio­phar­ma lead­ers

6 years ago
People
Special

GSK vac­cine chief heads for AIDS vac­cine ini­tia­tive; Pfiz­er en­lists Sue Desmond-Hell­mann to its board of di­rec­tors

6 years ago
Peer Review

Covid-19 roundup: Mod­er­na CEO Stéphane Ban­cel be­comes a bil­lion­aire; No­var­tis, In­cyte pitch Jakafi PhI­II to tack­le ...

6 years ago
R&D
Coronavirus

Sue Desmond-Hell­mann joins Pfiz­er board; Kite Phar­ma taps al­ly in push to ex­pand CAR-T

6 years ago
News Briefing

Covid-19 roundup: Trump push­es his new fa­vorite, untest­ed drug; CRISPR out­lines crip­pling im­pact of Covid-19

6 years ago
Coronavirus

My­ovant grabs $40M up­front in re­gion­al deal for re­l­u­golix; Akero an­nounces NASH suc­cess but Covid-19 de­lays

6 years ago
News Briefing

Covid-19 roundup: GSK, Am­gen tai­lor R&D work to fit the coro­n­avirus age; Doud­na's ge­nomics crew launch­es di­ag­nos­tic ...

6 years ago
Coronavirus

Jim Robin­son takes over the reins at Urovant; Car­los Cam­poy moves to Cy­tomX

6 years ago
Peer Review

Covid-19 roundup: In­ter­cept, blue­bird and a grow­ing list of biotechs feel the pain as pan­dem­ic man­gles FDA, R&D ...

6 years ago
Coronavirus

Oprah day in biotech: Re­ge­na­cy gets $30M, Ab­bisko gets $70M, Cas­tle Creek gets $75M

6 years ago
News Briefing

BEL­LUS Health buys IP rights, ban­ish­es roy­al­ties; Ab­b­Vie gets con­fir­ma­to­ry da­ta on ac­cel­er­at­ed AML drug

6 years ago
News Briefing

Covid-19 roundup: FDA stamps quick OK on Roche's Actem­ra PhI­II; AlloVir ex­pands Bay­lor pact

6 years ago
Coronavirus
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times